Transforming Obesity Management with FlyteHealth’s Personalized Approach with Gabe Castaneda, Chief Revenue Officer at FlyteHealth
Audio is streamed directly from the publisher (pfx.vpixl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
FlyteHealth achieves significant weight loss results, averaging 15.8% with non-GLP-1s and further improvements with GLP-1s.
In this episode, Gabe Castaneda, Chief Revenue Officer at FlyteHealth, talks about advancements and issues in obesity management, particularly focusing on GLP-1 medications. With 25 years of healthcare experience, Gabe highlights FlyteHealth’s innovative approach combining lifestyle management with clinical medication management. FlyteHealth's patented algorithm delivers personalized care, often utilizing non-GLP-1s to reduce costs and avoid side effects and aiming for sustainable weight loss. He also discusses the company's strategic partnerships and expansion plans, advocates for avoiding GLP-1s, and warns against compound prescriptions.
Tune in to discover how FlyteHealth is revolutionizing obesity management with innovative solutions!
Resources:
Connect with and follow Gabe Castaneda on LinkedIn.